(26), tumor ECs in distinct clusters based on the marker genes are lymphatic ECs (PDPN+ and PROX1+), tumor-derived blood ECs (FLT1+, IGFBP3+, and SPRY1+), and malignant or non-malignant ECs. The gene discussed is PROX1; the disease is neoplasm.